ADT	Androgen deprivation therapy
AML	Acute myeloid leukemia
BC	Breast cancer
BMI	Body mass index
CI	Confidence interval
CNS	Central nervous system
CRC	Colorectal cancer
CVD	Cardiovascular disease
EC	Endometrial cancer
GC	Gastric cancer
HCT	Hematopoietic cell transplantation
HR	Hazard ratio
HRQOL	Health-related quality of life
IGF-1R	Insulin growth factor receptor 1
IL-6	Interleukin-6
IRR	Incidence rate ratio
MCC	Multi-center cohort
MM	Multiple myeloma
n.a.	not available
NOS	the Newcastle-Ottawa Scale for cohort studies
OC	Ovarian cancer
OR	Odds ratio
PBC	Population-based cohort
PC	Prostate cancer
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RR	Relative risk
SCC	Single center cohort
SCCHN	Squamous cell carcinoma of the head and neck
SMM	Smoldering multiple myeloma
STS	Soft tissue sarcoma
T1DM	Type 1 diabetes mellitus
T1DM	Type 2 diabetes mellitus
TeC	Testicular cancer
ThC	Primary thyroid cancer
TNF-α	Tumor necrosis factor-α